Facing a growing outbreak of measles, the U.K. unveiled an advertising campaign ...
Amid concerns over Joe Biden's health and age, his physician says the president ...
In describing drugs in its pipeline, Pfizer noted that the mix of small molecule...
“The solution still is in the transformation of food systems and the environment...
Welcome to STAT Madness, a bracket-style contest to find the best innovation in ...
Change Healthcare cyberattack outage could persist for weeks, UnitedHealth Group...
The new vaccines that protect older adults against RSV may be linked to a small ...
What does America’s crackdown on Chinese firms like WuXi mean for the U.S. biote...
This week on "The Readout LOUD": Are biotech's dog days over? What's a PIPE? And...
A House panel is hearing two bills that weaken different requirements in Medicar...
Novo Nordisk can barely make enough of Wegovy to satisfy demand for the dramatic...
In an interview with Pharmaceutical Technology, the company’s chief scientific o...
Biotechs need to navigate US-China relations when pursuing collaborations and dr...
IRA regulations have changed how pharma is approaching innovation in cancer drug...
As post-approval boundaries disproportionately affect rare disease patients, com...
The Phase III VELA programme will compare the IL-17 inhibitor sonelokimab to a p...
